Harfst & Associates’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-985
Closed -$277K 115
2025
Q3
$277K Hold
985
0.05% 99
2025
Q2
$215K Buy
+985
New +$159K 0.04% 97
2022
Q3
Sell
-7,150
Closed -$499K 108
2022
Q2
$499K Sell
7,150
-4,188
-37% -$307K 0.14% 85
2022
Q1
$937K Buy
11,338
+1,247
+12% +$101K 0.22% 75
2021
Q4
$880K Buy
10,091
+413
+4% +$38.8K 0.22% 73
2021
Q3
$843K Sell
9,678
-453
-4% -$40K 0.23% 74
2021
Q2
$788K Sell
10,131
-1,408
-12% -$110K 0.23% 81
2021
Q1
$809K Buy
11,539
+2,943
+34% +$191K 0.24% 83
2020
Q4
$556K Buy
8,596
+2,954
+52% +$176K 0.2% 80
2020
Q3
$336K Buy
5,642
+185
+3% +$10.5K 0.14% 92
2020
Q2
$301K Buy
5,457
+174
+3% +$9.22K 0.13% 85
2020
Q1
$255K Sell
5,283
-12,672
-71% -$654K 0.13% 86
2019
Q4
$951K Buy
17,955
+495
+3% +$27.2K 0.37% 35
2019
Q3
$960K Buy
17,460
+500
+3% +$27.6K 0.4% 26
2019
Q2
$966K Buy
16,960
+787
+5% +$42.6K 0.39% 21
2019
Q1
$868K Buy
16,173
+1,081
+7% +$55.1K 0.37% 22
2018
Q4
$681K Buy
15,092
+869
+6% +$41.6K 0.33% 22
2018
Q3
$733K Buy
14,223
+577
+4% +$28K 0.31% 20
2018
Q2
$601K Buy
13,646
+550
+4% +$25.3K 0.25% 23
2018
Q1
$599K Buy
13,096
+1,018
+8% +$50.6K 0.24% 24
2017
Q4
$571K Buy
12,078
+309
+3% +$15.2K 0.23% 28
2017
Q3
$569K Buy
11,769
+47
+0.4% +$2.34K 0.24% 23
2017
Q2
$587K Buy
11,722
+3,149
+37% +$144K 0.24% 23
2017
Q1
$382K Buy
8,573
+848
+11% +$35.3K 0.17% 36
2016
Q4
$297K Buy
7,725
+2,431
+46% +$95.1K 0.15% 53
2016
Q3
$207K Sell
5,294
-36,735
-87% -$1.5M 0.11% 68
2016
Q2
$1.72M Buy
+42,029
New +$1.68M 0.69% 34
2016
Q1
Sell
-41,863
Closed -$1.53M 188
2015
Q4
$1.53M Buy
41,863
+1,000
+2% +$38.2K 0.62% 35
2015
Q3
$1.48M Buy
40,863
+37,804
+1,236% +$1.45M 0.65% 40
2015
Q2
$123K Buy
+3,059
New +$133K 0.07% 109

Other funds holding ORCL

Harfst & Associates's ORCL Position: Q4 2025 in Review

Harfst & Associates sold out of Oracle (ORCL) in Q4 2025, closing a stake of 985 shares — an estimated $277K sold.

Harfst & Associates first reported a position in ORCL in Q2 2015 and held it in 30 quarters. The position peaked at $1.72M in Q2 2016. 3,760 funds tracked by Wall St. Rank hold ORCL as of Q4 2025.

  • Harfst & Associates reported no remaining Oracle position as of Q4 2025 after selling out during the quarter.
  • Harfst & Associates sold 985 Oracle shares in Q4 2025, an estimated $277K.
  • Harfst & Associates first reported a position in Oracle in Q2 2015 and held it in 30 quarters.
  • Harfst & Associates's Oracle position peaked at $1.72M in Q2 2016.
  • 3,760 funds tracked by Wall St. Rank held Oracle as of Q4 2025.

Based on Harfst & Associates's 13F filing for Q4 2025, filed 10 Feb 2026.